Matrix metalloproteinases and epidermal wound repair

Cell and Tissue Research

Volumn 351, Issue 2, 2013, Pages 255-268

  Martins, Vera L ^a   Caley, Matthew ^a   O'Toole, Edel A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Epidermis; Keratinocyte; MMP; TIMPs; Wound

Indexed keywords

ADAM PROTEIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 26; METALLOPROTEINASE; PROTEIN ADAMTS; STROMELYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN FIBROBLAST; SKIN INJURY; STRUCTURAL HOMOLOGY; WOUND HEALING; ANIMAL; CYTOLOGY; ENZYMOLOGY; EPIDERMIS; KERATINOCYTE; METABOLISM; PHYSIOLOGY;

ANIMALS; EPIDERMIS; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASES; WOUND HEALING;

EID: 84877687065     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-012-1410-z     Document Type: Review

References (142)

1. Ahokas K, Skoog T, Suomela S, Jeskanen L, Impola U et al (2005) Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis. J Invest Dermatol 124:849-856
2. Atkinson JJ, Toennies HM, Holmbeck K, Senior RM (2007) Membrane type 1 matrix metalloproteinase is necessary for distal airway epithelial repair and keratinocyte growth factor receptor expression after acute injury. Am J Physiol Lung Cell Mol Physiol 293:L600-L610
3. Baker AH, Edwards DR, Murphy G (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115:3719-3727
4. Betsuyaku T, Fukuda Y, Parks WC, Shipley JM, Senior RM (2000) Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol 157:525-535
5. Blaydon DC, Biancheri P, Di WL, Plagnol V, Cabral RM et al (2011) Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 365:1502-1508
6. Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK et al (1999a) Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg 230:260-265
7. Bullard KM, Mudgett J, Scheuenstuhl H, Hunt TK, Banda MJ (1999b) Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. J Surg Res 84:31-34
8. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D et al (1995) Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104:236-240
9. Castaneda FE, Walia B, Vijay-Kumar M, Patel NR, Roser S et al (2005) Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 129:1991-2008
10. Chen P, Parks WC (2009) Role of matrix metalloproteinases in epithelial migration. J Cell Biochem 108:1233-1243
11. Chen P, Abacherli LE, Nadler ST, Wang Y, Li Q, Parks WC (2009) MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation. PLoS One 4:e6565
12. Chin GA, Thigpin TG, Perrin KJ, Moldawer LL, Schultz GS (2003) Treatment of chronic ulcers in diabetic patients with a topical metalloproteinase inhibitor, doxycycline. Wounds 15:315-323
13. Clark RAF (1995) Wound repair: overview and general considerations. In: Clark RAF (ed) The molecular and cellular biology of wound repair (second edition). Plenum, New York, pp 3-50
14. Cook H, Davies KJ, Harding KG, Thomas DW (2000) Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 115:225-233
15. Cornelius LA, Nehring LC, Harding E, Bolanowski M, Welgus HG et al (1998) Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 161:6845-6852
16. Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387-2392
17. Dallas SL, Rosser JL, Mundy GR, Bonewald LF (2002) Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 277:21352-21360
18. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R et al (2001) MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263:209-223
19. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM et al (1998) Matrilysin expression and function in airway epithelium. J Clin Invest 102:1321-1331
20. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ et al (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904
21. Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29:258-289
22. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T et al (2003) Cleavage of syndecan-1 by membrane type matrix metalloproteinase- 1 stimulates cell migration. J Biol Chem 278:40764-40770
23. Fini ME, Parks WC, Rinehart WB, Girard MT, MatsubaraMet al (1996) Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 149:1287-1302
24. Franzke CW, Tasanen K, Borradori L, Huotari V, Bruckner-Tuderman L (2004) Shedding of collagen XVII/BP180: structural motifs influence cleavage from cell surface. J Biol Chem 279:24521-24529
25. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277:225-228
26. Gill SE, Parks WC (2008) Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40:1334-1347
27. Gill SE, Pape MC, Khokha R, Watson AJ, Leco KJ (2003) A null mutation for tissue inhibitor of metalloproteinases-3 (Timp-3) impairs murine bronchiole branching morphogenesis. Dev Biol 261:313-323
28. Gilles C, Polette M, Coraux C, Tournier JM, Meneguzzi G et al (2001) Contribution of MT1-MMP and of human laminin-5 gamma2 chain degradation to mammary epithelial cell migration. J Cell Sci 114:2967-2976
29. Gross J, Lapiere CM (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 48:1014-1022
30. Gutierrez-Fernandez A, Inada M, Balbin M, Fueyo A, Pitiot AS et al (2007) Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 21:2580-2591
31. Haines P, Samuel GH, Cohen H, Trojanowska M, Bujor AM (2011) Caveolin-1 is a negative regulator of MMP-1 gene expression in human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling pathway. J Dermatol Sci 64:210-216
32. Hakkinen L, Uitto VJ, Larjava H (2000) Cell biology of gingival wound healing. Periodontol 2000(24):127-152
33. Harsha A, Stojadinovic O, Brem H, Sehara-Fujisawa A, Wewer U et al (2008) ADAM12: a potential target for the treatment of chronic wounds. J Mol Med (Berl) 86:961-969
34. Hartenstein B, Dittrich BT, Stickens D, Heyer B, Vu TH et al (2006) Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J Invest Dermatol 126:486-496
35. Hasty KA, Hibbs MS, Kang AH, Mainardi CL (1986) Secreted forms of human neutrophil collagenase. J Biol Chem 261:5645-5650
36. Hattori N, Mochizuki S, Kishi K, Nakajima T, Takaishi H et al (2009) MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol 175:533-546
37. Heckmann M, Adelmann-Grill BC, Hein R, Krieg T (1993) Biphasic effects of interleukin-1 alpha on dermal fibroblasts: enhancement of chemotactic responsiveness at low concentrations and of mRNA expression for collagenase at high concentrations. J Invest Dermatol 100:780-784
38. Heljasvaara R, Nyberg P, Luostarinen J, Parikka M, Heikkila P et al (2005) Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 307:292-304
39. Hieta N, Impola U, Lopez-Otin C, Saarialho-Kere U, Kahari VM (2003) Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J Invest Dermatol 121:997-1004
40. Higashiyama S, Nanba D (2005) ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. Biochim Biophys Acta 1751:110-117
41. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M et al (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92
42. Igata T, Jinnin M, Makino T, Moriya C, Muchemwa FC et al (2010) Up-regulated type I collagen expression by the inhibition of Rac1 signaling pathway in human dermal fibroblasts. Biochem Biophys Res Commun 393:101-105
43. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y (1997) Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322(Pt 3):809-814
44. Inoue M, Kratz G, Haegerstrand A, Stahle-Backdahl M (1995) Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol 104:479-483
45. Johnsen M, Lund LR, Romer J, Almholt K, Dano K (1998) Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10:667-671
46. Juncker-Jensen A, Lund LR (2011) Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice. PLoS One 6:e16954
47. Kajita M, Itoh Y, Chiba T, Mori H, Okada A et al (2001) Membranetype 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153:893-904
48. Kato T, Kure T, Chang JH, Gabison EE, Itoh T et al (2001) Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 508:187-190
49. Kivisaari AK, Kallajoki M, Mirtti T, McGrath JA, Bauer JW et al (2008) Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol 158:778-785
50. Kivisaari AK, Kallajoki M, Ala-aho R, McGrath JA, Bauer JW et al (2010) Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. Br J Dermatol 163:726-735
51. Klein T, Bischoff R (2011) Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure. J Proteome Res 10:17-33
52. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V (2000) Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148:615-624
53. Krampert M, Bloch W, Sasaki T, Bugnon P, Rulicke T et al (2004) Activities of the matrix metalloproteinase stromelysin-2 (MMP- 10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 15:5242-5254
54. Krampert M, Kuenzle S, Thai SN, Lee N, Iruela-Arispe ML, Werner S (2005) ADAMTS1 proteinase is up-regulated in wounded skin and regulates migration of fibroblasts and endothelial cells. J Biol Chem 280:23844-23852
55. Kure T, Chang JH, Kato T, Hernandez-Quintela E, Ye H et al (2003) Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest Ophthalmol Vis Sci 44:137-144
56. Larjava H, Haapasalmi K, Salo T, Wiebe C, Uitto VJ (1996) Keratinocyte integrins in wound healing and chronic inflammation of the human periodontium. Oral Dis 2:77-86
57. Lechapt-Zalcman E, Pruliere-Escabasse V, Advenier D, Galiacy S, Charriere-Bertrand C et al (2006) Transforming growth factorbeta1 increases airway wound repair via MMP-2 upregulation: a new pathway for epithelial wound repair? Am J Physiol Lung Cell Mol Physiol 290:L1277-L1282
58. Levi E, Fridman R, Miao HQ, Ma YS, Yayon A, Vlodavsky I (1996) Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci U S A 93:7069-7074
59. Li Q, Park PW, Wilson CL, Parks WC (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635-646
60. Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242:201-210
61. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F et al (2005) ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci U S A 102:9182-9187
62. Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K et al (2000) Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J Biol Chem 275:22695-22703
63. Mauch C, Zamek J, Abety AN, Grimberg G, Fox JW, Zigrino P (2010) Accelerated wound repair in ADAM-9 knockout animals. J invest Dermatol 130:2120-2130
64. Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53:288-295
65. Mauviel A, Uitto J (1993) The extracellular-matrix in wound-healing role of the cytokine network. Wounds 5:137-152
66. Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA et al (2005) A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res 65:4728-4738
67. McCawley LJ, O'Brien P, Hudson LG (1998) Epidermal growth factor (EGF)- and scatter factor/hepatocyte growth factor (SF/HGF)- mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol 176:255-265
68. McGuire JK, Li Q, Parks WC (2003) Matrilysin (matrix metalloproteinase- 7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 162:1831-1843
69. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF (2007) Impaired wound healing. Clin Dermatol 25:19-25
70. Mignatti P, Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195
71. Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F et al (2002) Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 277:2065-2072
72. Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E et al (1996) Temporal study of the activity ofmatrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 60:379-386
73. Mulholland B, Tuft SJ, Khaw PT (2005) Matrix metalloproteinase distribution during early corneal wound healing. Eye 19:584-588
74. Murphy G, Cockett MI, Ward RV, Docherty AJ (1991) Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 277(Pt 1):277-279
75. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494
76. Nwomeh BC, Liang HX, Cohen IK, Yager DR (1999) MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 81:189-195
77. Oh J, Seo DW, Diaz T, Wei B, Ward Yet al (2004) Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res 64:9062-9069
78. Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P (1997) Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 137:67-77
79. O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, Folkman J, Moses MA (1999) Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 274:29568-29571
80. O'Toole EA, Marinkovich MP, Peavey CL, Amieva MR, Furthmayr H et al (1997) Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest 100:2881-2891
81. O'Toole EA, van Koningsveld R, Chen M, Woodley DT (2008) Hypoxia induces epidermal keratinocytematrixmetalloproteinase-9 secretion via the protein kinase C pathway. J Cell Physiol 214:47-55
82. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657-672
83. Parks WC, Wilson CL, Lopez-Boado YS (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4:617-629
84. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, ParksWC (1997) The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 137:1445-1457
85. Pilcher BK, Dumin J, Schwartz MJ, Mast BA, Schultz GS et al (1999) Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J Biol Chem 274:10372-10381
86. Porras-Reyes BH, Blair HC, Jeffrey JJ, Mustoe TA (1991) Collagenase production at the border of granulation tissue in a healing wound: macrophage and mesenchymal collagenase production in vivo. Connect Tissue Res 27:63-71
87. Porter S, Clark IM, Kevorkian L, Edwards DR (2005) The ADAMTS metalloproteinases. Biochem J 386:15-27
88. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C (2003) Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4:544-558
89. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L et al (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9:407-415
90. Rechardt O, Elomaa O, Vaalamo M, Paakkonen K, Jahkola T et al (2000) Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 115:778-787
91. Roy R, Wewer UM, Zurakowski D, Pories SE, Moses MA (2004) ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem 279:51323-51330
92. Ryan MC, Tizard R, VanDevanter DR, Carter WG (1994) Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. J Biol Chem 269:22779-22787
93. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC (1993) Cellmatrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 92:2858-2866
94. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG (1994) Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 94:79-88
95. Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg ML (1996) Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 148:519-526
96. Saarialho-Kere U, Kerkela E, Jahkola T, Suomela S, Keski-Oja J, Lohi J (2002) Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J Invest Dermatol 119:14-21
97. Sadowski T, Dietrich S, Koschinsky F, Sedlacek R (2003) Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol Biol Cell 14:4569-4580
98. Sahin U, Blobel CP (2007) Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17. FEBS letters 581:41-44
99. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S et al (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164:769-779
100. Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H (1994) Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70:176-182
101. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C et al (2001) Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276:13372-13378
102. Sawicki G, Marcoux Y, Sarkhosh K, Tredget EE, Ghahary A (2005) Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol Cell Biochem 269:209-216
103. Scholz F, Schulte A, Adamski F, Hundhausen C, Mittag J et al (2007) Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin. J Invest Dermatol 127:1444-1455
104. Seiki M (2002) The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol 14:624-632
105. Sottrup-Jensen L, Birkedal-Hansen H (1989) Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alphamacroglobulins. J Biol Chem 264:393-401
106. Steffensen B, Hakkinen L, Larjava H (2001) Proteolytic events of wound-healingcoordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med 12:373-398
107. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516
108. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX et al (1995) The metzincins topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 4:823-840
109. Strachan L, Murison JG, Prestidge RL, Sleeman MA, Watson JD, Kumble KD (2001) Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J Biol Chem 276:18265-18271
110. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338
111. Sudbeck BD, Pilcher BK, Welgus HG, Parks WC (1997) Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J Biol Chem 272:22103-22110
112. Surendran K, Simon TC, Liapis H, McGuire JK (2004) Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4. Kidney Int 65:2212-2222
113. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M et al (1998) Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A 95:13221-13226
114. Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H et al (2004) The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res 10:5572-5579
115. Tang BL (2001) ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 33:33-44
116. Terasaki K, Kanzaki T, Aoki T, Iwata K, Saiki I (2003) Effects of recombinant human tissue inhibitor of metalloproteinases-2 (rh-TIMP-2) on migration of epidermal keratinocytes in vitro and wound healing in vivo. J Dermatol 30:165-172
117. Toriseva M, Kahari VM (2009) Proteinases in cutaneous wound healing. Cell Mol Life Sci 66:203-224
118. Tu G, Xu W, Huang H, Li S (2008) Progress in the development of matrix metalloproteinase inhibitors. Curr Med Chem 15:1388-1395
119. Unemori EN, Hibbs MS, Amento EP (1991) Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88:1656-1662
120. Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P et al (1996) Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 135:52-59
121. Vaalamo M, Leivo T, Saarialho-Kere U (1999) Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 30:795-802
122. Van Lint P, Libert C (2007) Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82:1375-1381
123. Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87:5578-5582
124. Vartak DG, Gemeinhart RA (2007) Matrix metalloproteases: underutilized targets for drug delivery. J Drug Target 15:1-20
125. Velasco J, Li J, DiPietro L, Stepp MA, Sandy JD, Plaas A (2011) Adamts5 deletion blocks murine dermal repair through CD44- mediated aggrecan accumulation and modulation of transforming growth factor beta1 (TGFbeta1) signaling. J Biol Chem 286:26016-26027
126. Veves A, Sheehan P, Pham HT (2002) A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137:822-827
127. Vin F, Teot L, Meaume S (2002) The healing properties of Promogran in venous leg ulcers. J Wound Care 11:335-341
128. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839
129. Wall SJ, Bevan D, Thomas DW, Harding KG, Edwards DR, Murphy G (2002) Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Invest Dermatol 119:91-98
130. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271:10079-10086
131. Widgerow AD (2011) Chronic wound fluid thinking outside the box. Wound Repair Regen 19:287-291
132. Wild-Bode C, Fellerer K, Kugler J, Haass C, Capell A (2006) A basolateral sorting signal directs ADAM10 to adherens junctions and is required for its function in cell migration. J Biol Chem 281:23824-23829
133. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS et al (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113-117
134. Wolfsberg TG, Straight PD, Gerena RL, Huovila A-PJ, Primakoff P et al (1995) ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol 169:378-383
135. Wysocki AB, Staiano-Coico L, Grinnell F (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-68
136. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK (1996) Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 107:743-748
137. Yan C, Boyd DD (2007) Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211:19-26
138. Yin J, Yu FS (2009) ERK1/2 mediate wounding- and G-proteincoupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci 50:132-139
139. Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176
140. Zhang X, Nothnick WB (2005) The role and regulation of the uterine matrix metalloproteinase system in menstruating and nonmenstruating species. Front Biosci 10:353-366
141. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY et al (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A 97:4052-4057
142. Zweers MC, Davidson JM, Pozzi A, Hallinger R, Janz K et al (2007) Integrin alpha2beta1 is required for regulation of murine wound angiogenesis but is dispensable for reepithelialization. J Invest Dermatol 127:467-478